Glyrx-pf Injection, Solution
Product Images NDC 51754-6001

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Glyrx-pf (NDC 51754-6001). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Exela Pharma Sciences, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Image 01)

An instructional illustration depicting two hands preparing a syringe. One hand holds a vial or syringe cap while the other hand is twisting or removing it, indicating a step in medication preparation or administration for injection.*

FDA Label Image

Exela Logo (Image 02)

FDA Label Image

1 mL Carton (Image 03)

Chemical structure diagram depicting the molecular formula of glycopyrrolate, the active ingredient in GLYRX-PF injection solution 0.2 mg/mL by Exela Pharma Sciences, LLC.*

FDA Label Image

1 mL Vial (Image 04)

The label for GLYRX-PF glycopyrrolate injection, a 0.2 mg/mL solution in a 5 mL single-dose prefilled syringe. The label includes dosing marks from 1 mL to 5 mL, instructions to discard unused portions, and states the product is for intramuscular or intravenous use. The labeler is Exela Pharma Sciences, LLC.*

FDA Label Image

2 mL Vial (Image 05)

GLYRX-PF Glycopyrrolate Injection packaging label for 1 mg/5 mL (0.2 mg/mL) solution in single-dose prefilled syringes. The label specifies intravenous or intramuscular use and instructs to discard unused portions. The product is labeled by Exela Pharma Sciences, LLC and marked Rx Only.*

FDA Label Image

2 mL Carton (Image 06)

Label for GLYRX-PF glycopyrrolate injection, solution with a concentration of 0.2 mg/mL. The label indicates a 1 mL single-dose vial intended for intravenous or intramuscular use. It includes the NDC number 51754-6000-1 and states the product is Rx only, manufactured by Exela Pharma Sciences, LLC.*

FDA Label Image

Image 07

The packaging label for GLYRX-PF glycopyrrolate injection, 0.2 mg/mL, displays the product name and strength prominently. It is indicated for intravenous or intramuscular use, with packaging containing 25 single-dose 1 mL vials. The labeler is Exela Pharma Sciences, LLC, based in Lenoir, NC. The label also notes storage conditions and pH information for the solution.*

FDA Label Image

Image 08

Label for GLYRX-PF Glycopyrrolate Injection 0.2 mg/mL solution, showing a 2 mL single-dose vial containing 0.4 mg total. The label states intravenous or intramuscular administration, with instructions to discard unused portions. The product is manufactured by Exela Pharma Sciences, LLC.*

FDA Label Image

Image 09

GLYRX-PF glycopyrrolate injection 0.4 mg/2 mL (0.2 mg/mL) carton label for intravenous or intramuscular use. The package contains 25 single-dose 2 mL vials and is labeled with usage instructions, storage conditions, and the manufacturer, Exela Pharma Sciences, LLC.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.